Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.078 AUD | -7.14% | -2.50% | -3.70% |
Mar. 20 | Australia's Tax Agency Publishes Ruling on Invex Therapeutics' Capital Return | MT |
Feb. 16 | Invex Therapeutics Narrows Fiscal H1 Loss on Lower R&D Expenses | MT |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Narelle Warren
DFI | Director of Finance/CFO | - | 19-02-28 |
Carol Parish
COO | Chief Operating Officer | - | - |
Thomas Duthy
BRD | Director/Board Member | - | 20-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David McAuliffe
CHM | Chairman | 58 | 19-03-07 |
Narelle Warren
DFI | Director of Finance/CFO | - | 19-02-28 |
Thomas Duthy
BRD | Director/Board Member | - | 20-09-30 |
Megan Baldwin
BRD | Director/Board Member | 49 | 21-02-15 |
David Wheeler
BRD | Director/Board Member | 65 | Nov. 07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 75,153,848 | 30,220,477 ( 40.21 %) | 0 | 40.21 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-3.70% | 3.87M | |
+23.37% | 47.02B | |
+49.84% | 41.86B | |
-0.94% | 41.76B | |
-4.32% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |
- Stock Market
- Equities
- IXC Stock
- Company Invex Therapeutics Ltd